Join the upcoming webinar: FAP Imaging and Theranostics: How to Cross the Finish Line
Date: Wednesday, May 5, 2026
Time: 11:00 am ET
FAP has quickly progressed from proof-of-concept to late-phase clinical development in oncology (with non-oncology indications following soon), gaining momentum toward diagnostic approval. But key challenges still remain.
Join us for a live, roundtable panel where industry and academic experts will examine how readiness across imaging infrastructure, site networks, and trained readers will shape FAP’s path from clinical trials to clinical practice.
Meet Our Panelists
- Dan Pryma, MD, VP, Global Clinical Development, Eli Lilly & Co.
- Jeremie Calais, MD, PhD, Associate Professor, Molecular & Medical Pharmacology, UCLA
- Phillip Kuo, MD, PhD, Consultant, Perceptive Imaging
- Sherly Mosessian, PhD, Chief Scientific Officer, SOFIE Biosciences
Also, don’t miss our SNMMI Symposium FAP in Focus – Oncology and Horizons Beyond Cancer at the upcoming SNMMI Annual meeting. LEARN MORE >